Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
International Ophthalmology
Published in: International Ophthalmology 4/2020

01-04-2020 | Photodynamic Therapy | Original Paper

Association between CFH single nucleotide polymorphisms and response to photodynamic therapy in patients with central serous chorioretinopathy

Authors: Dandan Linghu, Hui Xu, Zhiqiao Liang, Tingting Gao, Zhaojun Lin, Xiaoxin Li, Lvzhen Huang, Mingwei Zhao

Published in: International Ophthalmology | Issue 4/2020

Login to get access

Abstract

Purpose

To evaluate the association between single nucleotide polymorphisms (SNPs) in the complement factor H (CFH) gene and response to PDT in patients with CSC.

Methods

103 eyes from 93 patients with CSC were enrolled from Department of Ophthalmology of the People’s Hospital Peking University. Genotyping for selected SNPs in the CFH gene was performed, and multivariate linear analysis was used to identify factors influencing PDT treatment outcomes. Genetics associations between SNPs in the CFH gene and response to PDT in patients with CSC were analyzed.

Results

None of the seven SNPs examined in this study (rs800292, rs1061170, rs3753394, rs3753396, rs2284664, rs1329428, and rs1065489) showed significant associations with 1-month outcomes after PDT in patients with CSC (P > 0.05). Baseline BCVA changed at 1 month after PDT (P < 0.001), and baseline retinal thickness was associated with changes in retinal thickness at 1 month after PDT (P < 0.001). Age was significantly associated with resolution of SRF at 1 month after PDT (P = 0.004).

Conclusions

There were no significant associations between SNPs in the CFH gene and 1-month outcomes after PDT in patients with CSC. However, baseline BCVA, baseline retinal thickness, and age were significantly associated with response to PDT in patients with CSC. Larger studies with more power are necessary to further determine whether an association exists between SNPs in the CFH gene and PDT in patients with CSC.
Literature
1.
Wang M, Munch IC, Hasler PW et al (2008) Central serous chorioretinopathy. Acta Ophthalmol 86(2):126–145CrossRef
2.
Gemenetzi M, De Salvo G, Lotery AJ (2010) Central serous chorioretinopathy: an update on pathogenesis and treatment. Eye (London) 24(12):1743–1756CrossRef
3.
Nicholson B, Noble J, Forooghian F et al (2013) Central serous chorioretinopathy: update on pathophysiology and treatment. Surv Ophthalmol 58(2):103–126CrossRef
4.
Moon JW, Yu HG, Kim TW et al (2009) Prognostic factors related to photodynamic therapy for central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol 247(10):1315–1323CrossRef
5.
de Jong EK, Breukink MB, Schellevis RL et al (2015) Chronic central serous chorioretinopathy is associated with genetic variants implicated in age-related macular degeneration. Ophthalmology 122(3):562–570CrossRef
6.
Miki A, Kondo N, Yanagisawa S et al (2014) Common variants in the complement factor H gene confer genetic susceptibility to central serous chorioretinopathy. Ophthalmology 121(5):1067–1072CrossRef
7.
Moschos MM, Gazouli M, Gatzioufas Z et al (2016) Prevalence of the complement factor H and GSTM1 genes polymorphisms in patients with central serous chorioretinopathy. Retina 36(2):402–407CrossRef
8.
Huang L, Meng Q, Zhang C et al (2015) Gene-gene interaction of CFH, ARMS2, and ARMS2/HTRA1 on the risk of neovascular age-related macular degeneration and polypoidal choroidal vasculopathy in Chinese population. Eye 29:691–698CrossRef
9.
Quin G, Liew G, Ho IV et al (2013) Diagnosis and interventions for central serous chorioretinopathy: review and update. Clin Exp Ophthalmol 41(2):187–200CrossRef
10.
Yannuzzi LA (2010) Central serous chorioretinopathy: a personal perspective. Am J Ophthalmol 149(3):361–363CrossRef
11.
Zhao M, Zhang F, Chen Y et al (2015) A 50% vs 30% dose of verteporfin (photodynamic therapy) for acute central serous chorioretinopathy: one-year results of a randomized clinical trial. JAMA Ophthalmol 133(3):333–340CrossRef
12.
Kim YK, Ryoo NK, Woo SJ et al (2015) Choroidal thickness changes after photodynamic therapy and recurrence of chronic central serous chorioretinopathy. Am J Ophthalmol 160(1):72–84CrossRef
13.
Tsai MJ, Hsieh YT (2014) Half-time photodynamic therapy for central serous chorioretinopathy. Optom Vis Sci 91(9):1140–1145CrossRef
14.
Haga F, Maruko R, Sato C et al (2017) Long-term prognostic factors of chronic central serous chorioretinopathy after half-dose photodynamic therapy: a 3-year follow-up study. PLoS ONE 12(7):e0181479CrossRef
15.
Siaudvytyte L, Diliene V, Miniauskiene G et al (2012) Photodynamic therapy and central serous chorioretinopathy. Med Hypothesis Discovery Innov Ophthalmol J 1(4):67–71
Metadata
Title
Association between CFH single nucleotide polymorphisms and response to photodynamic therapy in patients with central serous chorioretinopathy
Authors
Dandan Linghu
Hui Xu
Zhiqiao Liang
Tingting Gao
Zhaojun Lin
Xiaoxin Li
Lvzhen Huang
Mingwei Zhao
Publication date
01-04-2020
Publisher
Springer Netherlands
Published in
International Ophthalmology / Issue 4/2020
Print ISSN: 0165-5701
Electronic ISSN: 1573-2630
DOI
https://doi.org/10.1007/s10792-019-01261-y

Other articles of this Issue 4/2020

International Ophthalmology 4/2020 Go to the issue

Original Paper

Vitreous albumin redox state in open-angle glaucoma patients and controls: a pilot study

Original Paper

Comparison of 27-gauge versus 25-gauge vitrectomy results in patients with epiretinal membrane: 6-month follow-up

Original Paper

EDI-OCT choroidal thickness in Posner–Schlossman syndrome

Original Paper

Link of ocular pseudoexfoliation syndrome and vascular system changes: results from 10-year follow-up study

Original Paper

The influence of corneal geometrical and biomechanical properties on tonometry readings in keratoconic eyes

Original Paper

Characteristics of ‘sawtooth shunt’ following anti-vascular endothelial growth factor for aggressive posterior retinopathy of prematurity